Highlights from the Week of 08th June – 15th June in the world of pharma and healthcare!

Highlights from the week of 08th June - 15th June Sanofi ( FDA, Approval ) Sanofi's Tzield gets FDA approval to treat patients recently diagnosed with Stage 3 type 1 diabetes Eli Lilly ( FDA, Approval ) FDA grants approval to Eli Lilly's EBGLYSS 250 mg/2 mL SC injection for maintenance dosing to treat moderate-to-severe atopic dermatitis AstraZeneca ( FDA, Approval ) AstraZeneca's TRUQAP, in combination with abiraterone and prednisone, gains FDA approval to treat adults with mAPMN/S prostate cancer Novo Nordisk ( UK, Approval ) MHRA grants approval to Novo Nordisk's WEGOVY as an injectable treatment adjunct to a reduced-calorie diet and increased physical activity for obesity All logos and trademarks remain the intellectual properties of their respective owners

Connect with us

Please fill in the information below, and we'll get back to you.